Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program

Mueller, V; Banys-Paluchowski, M.; Friedl, T. W. P.; Fasching, P. A.; Schneeweiss, A.; Hartkopf, A.; Wallwiener, D.; Rack, B.; Meier-Stiegen, F.; Huober, J.; Ruebner, M.; Hoffmann, O.; Mueller, L.; Janni, W.; Wimberger, P.; Jaeger, B.; Pantel, K.; Riethdorf, S.; Harbeck, N.; Fehm, T.

dc.contributor.author	Hartkopf, Andreas
dc.contributor.author	Wallwiener, Diethelm
dc.date.accessioned	2022-05-30T10:34:30Z
dc.date.available	2022-05-30T10:34:30Z
dc.date.issued	2021
dc.identifier.issn	2059-7029
dc.identifier.uri	http://hdl.handle.net/10900/127534
dc.language.iso	en	de_DE
dc.publisher	Amsterdam	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.esmoop.2021.100299	de_DE
dc.subject.ddc	610	de_DE
dc.title	Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220404000000_00427
utue.personen.roh	Mueller, V
utue.personen.roh	Banys-Paluchowski, M.
utue.personen.roh	Friedl, T. W. P.
utue.personen.roh	Fasching, P. A.
utue.personen.roh	Schneeweiss, A.
utue.personen.roh	Hartkopf, A.
utue.personen.roh	Wallwiener, D.
utue.personen.roh	Rack, B.
utue.personen.roh	Meier-Stiegen, F.
utue.personen.roh	Huober, J.
utue.personen.roh	Ruebner, M.
utue.personen.roh	Hoffmann, O.
utue.personen.roh	Mueller, L.
utue.personen.roh	Janni, W.
utue.personen.roh	Wimberger, P.
utue.personen.roh	Jaeger, B.
utue.personen.roh	Pantel, K.
utue.personen.roh	Riethdorf, S.
utue.personen.roh	Harbeck, N.
utue.personen.roh	Fehm, T.
dcterms.isPartOf.ZSTitelID	Esmo Open	de_DE
dcterms.isPartOf.ZS-Issue	Article 100299	de_DE
dcterms.isPartOf.ZS-Volume	6 (6)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE